Your browser doesn't support javascript.
loading
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
de Beaurepaire, Renaud; Sinclair, Julia M A; Heydtmann, Mathis; Addolorato, Giovanni; Aubin, Henri-Jean; Beraha, Esther M; Caputo, Fabio; Chick, Jonathan D; de La Selle, Patrick; Franchitto, Nicolas; Garbutt, James C; Haber, Paul S; Jaury, Philippe; Lingford-Hughes, Anne R; Morley, Kirsten C; Müller, Christian A; Owens, Lynn; Pastor, Adam; Paterson, Louise M; Pélissier, Fanny; Rolland, Benjamin; Stafford, Amanda; Thompson, Andrew; van den Brink, Wim; Leggio, Lorenzo; Agabio, Roberta.
Afiliación
  • de Beaurepaire R; Groupe Hospitalier Paul-Guiraud, Villejuif, France.
  • Sinclair JMA; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Heydtmann M; Department of Gastroenterology, Royal Alexandra Hospital Paisley, Paisley, United Kingdom.
  • Addolorato G; AUD and Alcohol Related Diseases Unit, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
  • Aubin HJ; Department of Internal Medicine and Gastroenterology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Beraha EM; Faculté de Médecine, Centre de Recherche en Epidémiologie et Santé des Populations, Université Paris-Sud, Paris, France.
  • Caputo F; Faculté de Médecine, Université de Versailles Saint-Quentin-en-Yvelines, Paris, France.
  • Chick JD; Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Paris, France.
  • de La Selle P; Hôpitaux Universitaires Paris-Sud, Paris, France.
  • Franchitto N; Department of Psychology, University of Amsterdam, Amsterdam, Netherlands.
  • Garbutt JC; Department of Internal Medicine, SS. Annunziata Hospital, Cento, Italy.
  • Haber PS; Castle Craig Hospital, Blyth Bridge, United Kingdom.
  • Jaury P; School of Health and Social Care, Edinburgh Napier University, Edinburgh, United Kingdom.
  • Lingford-Hughes AR; Private Practice, Montpellier, France.
  • Morley KC; Department of Addiction Medicine, Poisons and Substance Abuse Treatment Centre, Toulouse-Purpan University Hospital, Toulouse, France.
  • Müller CA; Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Owens L; National Health Medical Research Council, Centre of Research Excellence in Mental Health and Substance Use, Central Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Pastor A; Drug Health Services, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Paterson LM; Département de Médecine Générale, Faculté de Médecine, Université Paris Descartes, Paris, France.
  • Pélissier F; Neuropsychopharmacology Unit, Division of Brain Sciences, Centre for Psychiatry, Imperial College London, London, United Kingdom.
  • Rolland B; Discipline of Addiction Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Stafford A; Department of Psychiatry, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Thompson A; Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, United Kingdom.
  • van den Brink W; Department Addiction Medicine, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
  • Leggio L; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Agabio R; Neuropsychopharmacology Unit, Division of Brain Sciences, Centre for Psychiatry, Imperial College London, London, United Kingdom.
Front Psychiatry ; 9: 708, 2018.
Article en En | MEDLINE | ID: mdl-30662411

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Psychiatry Año: 2018 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Psychiatry Año: 2018 Tipo del documento: Article País de afiliación: Francia